BGI Genomics Co., Ltd. (SHE:300676)

Market Cap	17.41B
Revenue (ttm)	3.71B
Net Income (ttm)	-799.91M
Shares Out	383.85M
EPS (ttm)	-1.93
PE Ratio	n/a
Forward PE	692.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,872,724
Average Volume	3,173,375
Open	45.35
Previous Close	45.36
Day's Range	45.31 - 47.56
52-Week Range	37.57 - 70.30
Beta	0.79
RSI	45.14
Earnings Date	Apr 25, 2026

About BGI Genomics

BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally. The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services. It also provides diagnostics and precis...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,702
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300676